BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death Dis 2020;11:902. [PMID: 33097691 DOI: 10.1038/s41419-020-03123-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mu X, Shen Z, Lin Y, Xiao J, Xia K, Xu C, Chen B, Shi R, Zhu A, Sun X, Tao T, Song X, Xuan Q, Zhao Y. LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/8693259] [Reference Citation Analysis]
2 Fornari F, Giovannini C, Piscaglia F, Gramantieri L. Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions. J Hepatocell Carcinoma 2021;8:741-57. [PMID: 34239844 DOI: 10.2147/JHC.S285726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Park Y, Han Y, Kim D, Cho S, Kim W, Hwang H, Lee HW, Han DH, Kim KS, Yun M, Lee M. Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells. Cancers 2022;14:1205. [DOI: 10.3390/cancers14051205] [Reference Citation Analysis]
4 Zheng Z, Lai C, Li W, Zhang C, Ma K, Yao Y. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer. Front Genet 2021;12:720421. [PMID: 34490046 DOI: 10.3389/fgene.2021.720421] [Reference Citation Analysis]
5 Zhao J, Wang Y, Su H, Su L. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review. Clin Res Hepatol Gastroenterol 2021;45:101736. [PMID: 34146723 DOI: 10.1016/j.clinre.2021.101736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat 2021;:100797. [PMID: 34955385 DOI: 10.1016/j.drup.2021.100797] [Reference Citation Analysis]
7 Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G. Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. J Hepatocell Carcinoma 2021;8:1415-44. [PMID: 34858888 DOI: 10.2147/JHC.S336858] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fu X, Zhang J, Huang X, Mo Z, Sang Z, Duan W, Huang W. Curcumin Antagonizes Glucose Fluctuation-Induced Renal Injury by Inhibiting Aerobic Glycolysis via the miR-489/LDHA Pathway. Mediators Inflamm 2021;2021:6104529. [PMID: 34456629 DOI: 10.1155/2021/6104529] [Reference Citation Analysis]
9 Shrestha R, Bridle KR, Cao L, Crawford DHG, Jayachandran A. Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells. Curr Oncol 2021;28:2150-72. [PMID: 34208001 DOI: 10.3390/curroncol28030200] [Reference Citation Analysis]
10 Xu XF, Yang XK, Song Y, Chen BJ, Yu X, Xu T, Chen ZL. Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies. Pharmacol Res 2021;:105906. [PMID: 34543740 DOI: 10.1016/j.phrs.2021.105906] [Reference Citation Analysis]
11 Xia R, Tang H, Shen J, Xu S, Liang Y, Zhang Y, Gong X, Min Y, Zhang D, Tao C, Wang S, Zhang Y, Yang J, Wang C. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. Cancer Cell Int 2021;21:154. [PMID: 33663535 DOI: 10.1186/s12935-021-01857-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Huang P, Zhu S, Liang X, Zhang Q, Luo X, Liu C, Song L. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives. Cancer Manag Res 2021;13:5317-36. [PMID: 34262341 DOI: 10.2147/CMAR.S314502] [Reference Citation Analysis]
13 Mu J, Sun X, Zhao Z, Sun H, Sun P. BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors. Cell Death Dis 2021;12:962. [PMID: 34667163 DOI: 10.1038/s41419-021-04186-6] [Reference Citation Analysis]
14 Wang X, Wei X, Cao Y, Xing P. Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer. J Cell Mol Med 2022. [PMID: 35132755 DOI: 10.1111/jcmm.17210] [Reference Citation Analysis]
15 Hu X, Zhu H, Shen Y, Zhang X, He X, Xu X. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma. Front Oncol 2021;11:696705. [PMID: 34367979 DOI: 10.3389/fonc.2021.696705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Yang H, Zhang MZ, Sun HW, Chai YT, Li X, Jiang Q, Hou J. A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Front Oncol 2021;11:783194. [PMID: 34869036 DOI: 10.3389/fonc.2021.783194] [Reference Citation Analysis]
17 Liu R, Song Y, Li C, Zhang Z, Xue Z, Huang Q, Yu L, Zhu D, Cao Z, Lu A, Lu C, Liu Y. The naturally-occurring flavonoid nobiletin reverses methotrexate resistance via inhibition of P-glycoprotein synthesis. J Biol Chem 2022;:101756. [PMID: 35202652 DOI: 10.1016/j.jbc.2022.101756] [Reference Citation Analysis]
18 Chen S, Fu Z, Wen S, Yang X, Yu C, Zhou W, Lin Y, Lv Y. Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma. Front Genet 2021;12:666306. [PMID: 34163524 DOI: 10.3389/fgene.2021.666306] [Reference Citation Analysis]